Literature DB >> 1916688

Lymphocyte predominance Hodgkin's disease (nodular paragranuloma)--a bcl-2 negative germinal centre lymphoma.

P Algara1, P Martinez, L Sanchez, R Villuendas, J L Orradre, H Oliva, M A Piris.   

Abstract

Hodgkin's disease, lymphocyte predominance type (nodular paragranuloma), is of germinal centre origin and the tumour cells have a B-cell phenotype. As the T(14;18) translocation, and the subsequent expression of bcl-2 protein by germinal centre cells, is the most characteristic finding of centroblastic-centrocytic lymphoma, we have tested a series of 11 cases of lymphocyte predominance Hodgkin's disease, using Southern blot analysis for the major breakpoint region and the minor breakpoint cluster region, polymerase chain reaction with primers for the major and minor breakpoint cluster region, and immunohistological studies with a monoclonal antibody specific for the bcl-2 protein. All three techniques gave negative results in the cases of Hodgkin's disease, establishing a clear differentiation from centroblastic-centrocytic lymphoma. These findings are useful in the differential diagnosis between the two entities and raise the question of the non-clonal nature of lymphocyte predominance Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1916688     DOI: 10.1111/j.1365-2559.1991.tb00896.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  7 in total

1.  Composite follicular lymphoma and nodular lymphocyte predominance Hodgkin's disease.

Authors:  Jean-Louis Dargent; Laurence Lespagnard; Isabelle Meiers; Christophe Bradstreet; Pierre Heimann; Christiane De Wolf-Peeters
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

2.  Lymphocyte predominance Hodgkin's disease. Evidence for a kappa light chain-restricted monotypic B-cell neoplasm.

Authors:  M H Stoler; G E Nichols; M Symbula; L M Weiss
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

3.  Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.

Authors:  N M Jiwa; P Kanavaros; P van der Valk; J M Walboomers; A Horstman; W Vos; H Mullink; C J Meijer
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

4.  The bcl-2/JH gene rearrangement is undetectable in Hodgkin's lymphomas: results from the German Hodgkin trial.

Authors:  M Nolte; M Werner; W Spann; B Schnabel; R von Wasielewski; L Wilkens; K Hübner; R Fischer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Epstein-Barr virus infection and bcl-2 proto-oncogene expression. Separate events in the pathogenesis of Hodgkin's disease?

Authors:  G Khan; R K Gupta; P J Coates; G Slavin
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease.

Authors:  K F Izban; T Wrone-Smith; E D Hsi; B Schnitzer; M E Quevedo; S Alkan
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

Review 7.  Lymphocyte predominant Hodgkin's disease.

Authors:  Bradley C Ekstrand; Sandra J Horning
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.